MuSK항체 양성 중증근무력증
MuSK antibody positive myasthenia gravis
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Since Hoch et al reported the presence of antibodies to muscle specific receptor tyrosine kinase (MuSK) in seronegative myasthenia gravis (MG), MG with MuSK antibodies (MuSK-MG) has been reported to have unique clinical features, diagnostic problems and response to treatment. Patients with MuSK-MG have a tendency of early and frequent involvement of bulbar muscles, often associated with prominent facial or tongue atrophy. Diagnostic yields of edrophonium test, and electrophysiologic tests, such as repetitive nerve stimulation test (RNS) and single fiber electromyography (SFEMG) are lower than in patients with acetylcholine receptor antibodies (AChR-MG). When doing edrophonium test or treating with acetylchoinesterase inhibitors, they often show intolerance (muscarinic and nicotinic side effects) and even show worsening of muscle weakness (hypersensitivity). However, because most of studies included small numbers of MuSK-MG patients, there have been some discrepancies among reports. And there have been questions about pathogenesis of MuSK antibodies to induce muscle weakness.I would like review the pathogenesis, clinical features, diagnosis, and treatment of MuSK-MG
Abstract
Since Hoch et al reported the presence of antibodies to muscle specific receptor tyrosine kinase (MuSK) in seronegative myasthenia gravis (MG), MG with MuSK antibodies (MuSK-MG) has been reported to have unique clinical features, diagnostic problems and response to treatment. Patients with MuSK-MG have a tendency of early and frequent involvement of bulbar muscles, often associated with prominent facial or tongue atrophy. Diagnostic yields of edrophonium test, and electrophysiologic tests, such as repetitive nerve stimulation test (RNS) and single fiber electromyography (SFEMG) are lower than in patients with acetylcholine receptor antibodies (AChR-MG). When doing edrophonium test or treating with acetylchoinesterase inhibitors, they often show intolerance (muscarinic and nicotinic side effects) and even show worsening of muscle weakness (hypersensitivity). However, because most of studies included small numbers of MuSK-MG patients, there have been some discrepancies among reports. And there have been questions about pathogenesis of MuSK antibodies to induce muscle weakness.I would like review the pathogenesis, clinical features, diagnosis, and treatment of MuSK-MG
참고문헌 (42)
- Hoch W, "Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies", Nat Med, 7, pp.365~368 (2001)
- Pasnoor M, "Clinical findings in MuSK-antibody positive myasthenia gravis: a U.S. experience", Muscle Nerve, 41, pp.370~374 (2010)
- Guptill JT, "Anti-MuSK antibody myasthenia gravis: Clinical findings and response to treatment in two large cohorts", Muscle Nerve, 44, pp.36~40 (2011)
- Kim N, "Lrp4 is a receptor for agrin and forms a complex with MuSK", Cell, 135, pp.334~342 (2008)
- Linnoila J, "A mammalian homolog of Drosophilia tumorous imaginal discs, Tid1, mediates agrin signaling at the neuromuscular junction", Neuron, 60, pp.625~641 (2008)
- Scruderi F, "Anti-P100 autoantibodies identify a subtype of “seronegative”myasthenia gravis with prominent oculobulbar involvement", Lab Invet, 82, pp.1139~1146 (2002)
- DeChiara TM, "The receptor tyrosine kinase MuSK is required for neuromuscular junction formation in vivo", Cell, 85, pp.501~512 (1996)
- Shigemoto K, "Induction of myasthenia by immunization against muscle-specific kinase", J Clin Invest, 116, pp.1016~1024 (2006)
- McConville J, "Detection and characterization of MuSK antibodies in seronegative myasthenia gravis", Ann Neurol, 55, pp.580~584 (2004)
- Shiraishi H, "Acetycholine receptors loss and postsynaptic damage in MuSK antibody-positive myasthenia gravis", Ann Neurol, 57, pp.289~293 (2005)
- Selcen D, "Are MuSK antibodies the primary cause of myasthenic symptoms?", Neurology, 62, pp.1945~1950 (2004)
- Niks EH, "Pre-and postsynaptic neuromuscular junction abnormalities in MuSK myasthenia", Muscle Nerve, 42, pp.283~288 (2010)
- Romi F, "Seronegative myasthenia gravis: disease severity and prognosis", Eur J Neurol, 12, pp.413~418 (2005)
- Lee JY, "MUsK antibody-positive seronegative myasthenia gravis in Korea", J Clin Neurosci, 13, pp.353~355 (2006)
- Oh SJ, "Racial differences in myasthenia gravis in Alabama", Muscle Nerve, 39, pp.328~332 (2009)
- Ohta K, "MuSK antibodies in AChR Ab-seropositive MG vs AChR Ab-seronegative MG", Neurology, 62, pp.2122~2123 (2004)
- Saulact B, "Anti- MuSK antibodies after thymectomy in a previously seropositive child", Neurology, 69, pp.804~804 (2007)
- Caress JB, "Anyi-MuSK myasthenia gravis presenting with purely ocular findings", Ann Neurol, 62, pp.1002~1003 (2005)
- Bartoccioni E, "Anti-MuSK antibodies: Correlation with myasthenia gravis severity", Neurology, 67, pp.505~507 (2006)
- 오신중, "Muscle-Specific Receptor Tyrosine Kinase Antibody Positive Myasthenia Gravis Current Status", Journal of Clinical Neurology, 5(2), pp.53~64 (2009), 대한신경과학회
- Lauriola L, "Thymus changes in anti-MuSK-positive and -negative myasthenia gravis", Neurology, 64, pp.536~538 (2005)
- Leite MI, "Fewer thymic changes in MuSK antibody-positive than in MuSK antibody-negative MG", Ann Neurol, 57, pp.444~448 (2005)
- Martignago S, "Muscle histopathology in myasthenia gravis with antibodies against MuSK and AChR", Neuropathology and Applied Neurobiology, 35, pp.103~110 (2009)
- Strickler DE, "MuSK-antibody positive myasthenia gravis: clinical and electrophysiologic patterns", Clin Neurophysiol, 116, pp.2065~2068 (2005)
- Padua V, "Seronegative mysathenia gravis: comparison of neurophysiological picture in MuSK+ and MuSKpatients", Eur J Neurol, 13, pp.273~276 (2006)
- Farrugia ME, "MRI and clinical studies of facial and bulbar involvement in MuSK antibody-associated myasthenia gravis", Brain, 129, pp.1481~1492 (2006)
- Benveniste O, "MuSK antibody positive myasthenia gravis plasma modifies MURF-1 expression in C2C12 cultures and mouse muscle in vivo", Journal of Neuroimmunology, 170, pp.41~48 (2005)
- Boneva N, "Major pathogenic effects of anti-MuSK antibodies in myasthenia gravis", Journal of Neuroimmunolgy, 117, pp.119~131 (2006)
- Sanders DB, "Clinical aspects of MuSK antibody positive seronegative MG", Neurology, 60, pp.1978~1980 (2003)
- Kostera-Pruszczyk A, "MuSK-positive myasthenia gravis is rare in the Polish population", Eur J Neurol, 15, pp.720~724 (2008)
- Spengos K, "Dropped head syndrome as prominent clinical feature in MuSK-positive myasthenia gravis with thymus hyperplasia", Neuromuscular Disord, 18, pp.175~177 (2008)
- Hatanaka Y, "Nonresponsiveness to anticholinesterse agents in patients with MuSK-antibody-positive MG", Neurology, 65, pp.1508~1509 (2005)
- Evoli A, "Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis", Brain, 126, pp.2304~2311 (2003)
- Padua L, "Seronegative myasthenia gravis: comparision of neurophysiological picture in MuSK+ and MuSKpatients", European Journal of Neurology, 13, pp.273~276 (2006)
- Kuwabara S, "Anti-MuSK positive myasthenia gravis: neuromuscular transmission failure in facial and limb muscles", Acta Neurol Scand, 115, pp.126~128 (2007)
- Oh SJ, "Repetitive nerve stimulation of facial muscles in MuSK antibody-positive myasthenia gravis", Muscle Nerve, 33, pp.500~504 (2006)
- Evoli A, "Response to therapy in myasthenia gravis with anti-MuSK antibodies.", Ann NY Acad Sci, 1132, pp.76~83 (2008)
- Guptill JT, "Update on MuSK antibody positive myasthenia gravis", Curr Opin Neurol, 23, pp.530~535 (2010)
- Lavrnic D, "The features of myasthenia gravis with autoantibodies to MuSK", J Neuol Neurosurg Psychiatry, 76, pp.1099~1102 (2005)
- Drachman DB, "Treatment of refractory myasthenia: “rebooting”with high-dose cyclophosphamide", Ann Neurol, 53, pp.29~34 (2003)
- Lin PT, "High-dose cyclophosphamide in refractory myasthenia gravis with MuSK antibodies", Muscle Nerve, 33, pp.433~435 (2006)
- Farrugia ME, "Single-fiber elecromyography in limb and facial muscles in muscle-specific kinase antibody and acetylcholine receptor antibody myasthenia gravis", Muscle Nerve, 33, pp.568~570 (2006)